STAT5A and neoplasm: As well, Stat5a expression in breast cancer clinical cases was found to associate with histologic differentiation (low grade) and favorable prognosis, whereas loss of Stat5a expression was associated with tumor progression, unfavorable prognosis and increased risk of failure to antiestrogen therapy (90–94).